Home
Conditions
Hereditary Central Nervous System Demyelinating Diseases

Clinical trial condition

Hereditary Central Nervous System Demyelinating Diseases

Explore clinical trials studying Hereditary Central Nervous System Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

81 public trials 24 recruiting studies

Refine in advanced search Browse all conditions

Hereditary Central Nervous System Demyelinating Diseases trial results

Completed

Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)

NCT01510028

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: The Children's Hospital at Westmead Westmead, Australia

Rigshospitalet Copenhagen, Denmark

Hopital de Bicetre Le Kremlin-Bicêtre, Île-de-France Region, France

Center for Pediatric Clinical Studies Tübingen, Baden-Wurttemberg, Germany

View Trial Details

Completed

Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)

NCT00633139

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: PhaseOneTrials A/S Hvidovre, Denmark

View Trial Details

Completed

A Natural History Study of Canavan Disease

NCT02851563

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

NYU Langone Medical Center New York, United States

University Medical Center Hamburg-Eppendorf Hamburg, Germany

View Trial Details

Completed

Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool Children

NCT01938014

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +43 more
Locations: University of Chicago Chicago, Illinois, United States

University of Minnesota Minneapolis, Minnesota, United States

Hunter James Kelly Institute Buffalo, New York, United States

View Trial Details

Completed

Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy

NCT03864523

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +23 more
Locations: Bellvitge University Hospital L'Hospitalet de Llobregat, Barcelona, Spain

Donostia University Hospital Donostia / San Sebastian, Spain

View Trial Details

Completed

HSCT for High Risk Inherited Inborn Errors

NCT00383448

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +55 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants

NCT01495260

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +22 more
Locations: Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers

NCT03500627

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +22 more
Locations: Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States

View Trial Details

Completed

Exercise Study of Function and Pathology for Women With X-linked Adrenoleukodystrophy

NCT01594853

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +24 more
Locations: Motion Analysis Lab Baltimore, Maryland, United States

View Trial Details

Completed

Newborn Screening for Adrenoleukodystrophy

NCT02952482

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +21 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Hereditary Central Nervous System Demyelinating Diseases

Hereditary Central Nervous System Demyelinating Diseases trial results

Related conditions